MD HB1056 | 2024 | Regular Session
Status
Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 17-6)
Status: Passed on May 16 2024 - 100% progression
Action: 2024-05-16 - Approved by the Governor - Chapter 962
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Slight Partisan Bill (Democrat 17-6)
Status: Passed on May 16 2024 - 100% progression
Action: 2024-05-16 - Approved by the Governor - Chapter 962
Text: Latest bill text (Chaptered) [PDF]
Summary
Prohibiting a 340B manufacturer from taking certain direct or indirect actions to limit or restrict the acquisition or delivery of a 340B drug; making a violation of the Act an unfair, abusive, or deceptive trade practice within the meaning of the Consumer Protection Act; and requiring the Maryland Prescription Drug Affordability Board to conduct a study of the 340B Program and report its findings and recommendations to certain committees of the General Assembly by July 1, 2026.
Title
State Board of Pharmacy - Prohibition on Discrimination Against 340B Drug Distribution
Sponsors
Roll Calls
2024-04-06 - Senate - Third Reading Passed (Y: 35 N: 8 NV: 1 Abs: 3) [PASS]
2024-03-18 - House - Third Reading Passed (Y: 139 N: 0 NV: 1 Abs: 1) [PASS]
2024-03-18 - House - Third Reading Passed (Y: 139 N: 0 NV: 1 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-16 | House | Approved by the Governor - Chapter 962 |
| 2024-04-08 | House | Returned Passed |
| 2024-04-06 | Senate | Third Reading Passed (35-8) |
| 2024-04-05 | Senate | Second Reading Passed |
| 2024-04-05 | Senate | Favorable Adopted |
| 2024-04-05 | Senate | Motion Special Order until Later Today (Senator Hershey) Adopted |
| 2024-04-05 | Senate | Favorable |
| 2024-04-05 | Senate | Favorable Report by Finance |
| 2024-03-18 | Senate | Referred Finance |
| 2024-03-18 | House | Third Reading Passed (139-0) |
| 2024-03-16 | House | Second Reading Passed with Amendments |
| 2024-03-16 | House | Favorable with Amendments {563429/1 Adopted |
| 2024-03-16 | House | Favorable with Amendments Report by Health and Government Operations |
| 2024-02-09 | House | Hearing 2/29 at 1:00 p.m. |
| 2024-02-07 | House | First Reading Health and Government Operations |
Same As/Similar To
SB986 (Crossfiled) 2024-04-06 - Referred Rules and Executive Nominations
Subjects
Committees and Commissions
Consumer Protection
Discipline
Discrimination
Drugs
Federal Government
Health - Insurance
Health Occupations
Industry and Technology
Investigations and Inquiries
License Commissioners, Boards of
Penalties and Sentences
Pharmacists and Pharmacies
Reports
studies
Unfair Trade Practices
Wholesale Distribution
Consumer Protection
Discipline
Discrimination
Drugs
Federal Government
Health - Insurance
Health Occupations
Industry and Technology
Investigations and Inquiries
License Commissioners, Boards of
Penalties and Sentences
Pharmacists and Pharmacies
Reports
studies
Unfair Trade Practices
Wholesale Distribution
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| Commercial Law | 13 | 301 | (n/a) | See Bill Text |
| Health Occupations | 12 | 101 | (n/a) | See Bill Text |
| Health Occupations | 12 | 6C-09.1 | (n/a) | See Bill Text |
